MMP2 and breast carcinoma: A report on breast cancer cells in culture finds that these cells entering dormancy form a fibrillar fibronectin matrix and exits from dormancy require MMP‐2‐mediated fibronectin degradation (Barney et al., 2020), suggesting that stiff fibronectin matrices surrounding the tumor cells promote breast cancer dormancy.